P.127KER-050, a novel muscle anabolic, functions as a ligand trap that binds myo-catabolic TGFβ ligands and has reduced binding affinity for BMP9, a critical vascular remodeling ligand
Year: 2019
Type: article
Source: Neuromuscular Disorders
Authors: E. Lema, N. Kondratiev, R. Nathan, T. Backus, F. Fisher, J. Seehra, J. Lachey
Institution: Keros Therapeutics (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2975548068
